Literature DB >> 25363056

Comparability of total cardiovascular disease risk estimates using laboratory and non-laboratory based assessments in urban-dwelling South Africans: the CRIBSA study.

Nasheeta Peer1, Carl Lombard, Krisela Steyn, Thomas Gaziano, Naomi Levitt.   

Abstract

OBJECTIVES: To establish the prevalence and determinants of the 10-year risk of a cardiovascular disease (CVD) event in 25 - 74-year-old black Africans in Cape Town, South Africa, using Framingham laboratory- and non-laboratory-based and National Health and Nutrition Examination Survey (NHANES) I non-laboratory-based equations.
METHODS: CVD risk factors were determined by questionnaires, clinical measurements and biochemical analyses. Survey logistic regression analyses assessed the sociodemographic determinants of CVD risk ≥20%.
RESULTS: There were 1 025 participants, 369 men and 656 women. Mean 10-year risk for a CVD event by Framingham laboratory- and non-laboratory-based and NHANES I non-laboratory-based equations for men was 9.0% (95% confidence interval 7.7 - 10.3), 11.1% (9.6 - 12.6) and 9.0% (7.6 - 10.3), and for women 5.4% (4.7 - 6.1), 6.8% (5.9 - 7.7) and 8.7% (7.6 - 9.8). Correlations between laboratory- and non-laboratory-based scores were high (0.915 - 0.963). The prevalence of laboratory-based CVD risk ≥20% was 13.0% in men and 6.1% in women. In the logistic model for men, ≤7 years of education (odds ratio 3.09; 95% CI 1.67 - 5.71) and being unemployed (3.44; 1.21 - 9.81) compared with employed were associated with laboratory-based high risk. In women, high risk was associated with ≤7 years of education (4.20; 1.96 - 9.01), living in formal v. informal housing (2.74; 1.24 - 6.06) and being poor (middle v. lowest tertile 0.29; 0.13 - 0.66). In the Framingham non-laboratory-based logistic models there were no changes in the direction or significance of the variables except for housing, which was no longer significant in women.
CONCLUSIONS: Comparability of laboratory- and non-laboratory-based CVD risk estimates illustrates the utility of the latter in resource-constrained settings.

Entities:  

Mesh:

Year:  2014        PMID: 25363056      PMCID: PMC4816643          DOI: 10.7196/samj.8125

Source DB:  PubMed          Journal:  S Afr Med J


  13 in total

1.  The contribution of the Framingham Heart Study to the prevention of cardiovascular disease: a global perspective.

Authors:  Shanthi Mendis
Journal:  Prog Cardiovasc Dis       Date:  2010 Jul-Aug       Impact factor: 8.194

2.  South African hypertension guideline 2006.

Authors:  Y K Seedat; M A Croasdale; F J Milne; L H Opie; V J Pinkney-Atkinson; B L Rayner; Y Veriava
Journal:  S Afr Med J       Date:  2006-04

3.  The Framingham Heart Study's impact on global risk assessment.

Authors:  Asaf Bitton; Thomas A Gaziano
Journal:  Prog Cardiovasc Dis       Date:  2010 Jul-Aug       Impact factor: 8.194

4.  South African dyslipidaemia guideline consensus statement.

Authors:  Eric Klug
Journal:  S Afr Med J       Date:  2012-02-23

5.  Cost-effectiveness analysis of hypertension guidelines in South Africa: absolute risk versus blood pressure level.

Authors:  Thomas A Gaziano; Krisela Steyn; David J Cohen; Milton C Weinstein; Lionel H Opie
Journal:  Circulation       Date:  2005-12-06       Impact factor: 29.690

6.  Estimating wealth effects without expenditure data--or tears: an application to educational enrollments in states of India.

Authors:  D Filmer; L H Pritchett
Journal:  Demography       Date:  2001-02

7.  Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort.

Authors:  Thomas A Gaziano; Cynthia R Young; Garrett Fitzmaurice; Sidney Atwood; J Michael Gaziano
Journal:  Lancet       Date:  2008-03-15       Impact factor: 79.321

8.  Comparative assessment of absolute cardiovascular disease risk characterization from non-laboratory-based risk assessment in South African populations.

Authors:  Thomas A Gaziano; Ankur Pandya; Krisela Steyn; Naomi Levitt; Willie Mollentze; Gina Joubert; Corinna M Walsh; Ayesha A Motala; Annamarie Kruger; Aletta E Schutte; Datshana P Naidoo; Dorcas R Prakaschandra; Ria Laubscher
Journal:  BMC Med       Date:  2013-07-24       Impact factor: 8.775

9.  Rising diabetes prevalence among urban-dwelling black South Africans.

Authors:  Nasheeta Peer; Krisela Steyn; Carl Lombard; Estelle V Lambert; Bavanisha Vythilingum; Naomi S Levitt
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

10.  Decision-making using absolute cardiovascular risk reduction and incremental cost-effectiveness ratios: a case study.

Authors:  J A Ker; H Oosthuizen; P Rheeder
Journal:  Cardiovasc J Afr       Date:  2008 Mar-Apr       Impact factor: 1.167

View more
  7 in total

1.  Distribution and Performance of Cardiovascular Risk Scores in a Mixed Population of HIV-Infected and Community-Based HIV-Uninfected Individuals in Uganda.

Authors:  Anthony N Muiru; Prossy Bibangambah; Linda Hemphill; Ruth Sentongo; June-Ho Kim; Virginia A Triant; David R Bangsberg; Alexander C Tsai; Jeffrey N Martin; Jessica E Haberer; Yap Boum; Jorge Plutzky; Peter W Hunt; Samson Okello; Mark J Siedner
Journal:  J Acquir Immune Defic Syndr       Date:  2018-08-01       Impact factor: 3.731

Review 2.  Cardiovascular Complications of HIV in Endemic Countries.

Authors:  Matthew J Feinstein; Milana Bogorodskaya; Gerald S Bloomfield; Rajesh Vedanthan; Mark J Siedner; Gene F Kwan; Christopher T Longenecker
Journal:  Curr Cardiol Rep       Date:  2016-11       Impact factor: 2.931

3.  A Novel Risk Score to the Prediction of 10-year Risk for Coronary Artery Disease Among the Elderly in Beijing Based on Competing Risk Model.

Authors:  Long Liu; Zhe Tang; Xia Li; Yanxia Luo; Jin Guo; Haibin Li; Xiangtong Liu; Lixin Tao; Aoshuang Yan; Xiuhua Guo
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889

4.  Cost and consequence analysis of the Healthy Choices at Work programme to prevent non-communicable diseases in a commercial power plant, South Africa.

Authors:  Darcelle D Schouw; Robert Mash
Journal:  Afr J Prim Health Care Fam Med       Date:  2020-06-22

5.  Comparison of laboratory-based and non-laboratory-based WHO cardiovascular disease risk charts: a population-based study.

Authors:  Fatemeh Rezaei; Mozhgan Seif; Abdullah Gandomkar; Mohammad Reza Fattahi; Fatemeh Malekzadeh; Sadaf G Sepanlou; Jafar Hasanzadeh
Journal:  J Transl Med       Date:  2022-03-16       Impact factor: 5.531

6.  Metabolic Syndrome in South African Patients with Severe Mental Illness: Prevalence and Associated Risk Factors.

Authors:  Shamima Saloojee; Jonathan K Burns; Ayesha A Motala
Journal:  PLoS One       Date:  2016-02-16       Impact factor: 3.240

7.  Association of predicted 10 years cardiovascular mortality risk with duration of HIV infection and antiretroviral therapy among HIV-infected individuals in Durban, South Africa.

Authors:  Olamide O Todowede; Benn Sartorius; Nombulelo Magula; Aletta E Schutte
Journal:  Diabetol Metab Syndr       Date:  2019-12-16       Impact factor: 3.320

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.